These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10816800)

  • 1. [Electrophysiologic and anatomic atrial remodeling: an atrial rhythmic cardiomyopathy].
    Davy JM; Beck L; Pons M; Piot C
    Arch Mal Coeur Vaiss; 2000 Apr; 93(3 Spec No):39-45. PubMed ID: 10816800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electrophysiological remodeling induced by atrial fibrillation. An experimental curiosity or major factor in atrial fibrillation in man?].
    Piot O; Paziaud O; Digeos S; Copie X; Lavergne T; Guize L; Le Heuzey JY
    Arch Mal Coeur Vaiss; 2000 Jul; 93(7):841-8. PubMed ID: 10975036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
    Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K
    Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel anti-arrhythmic agents for the treatment of atrial fibrillation.
    Wettwer E; Christ T; Dobrev D; Ravens U
    Curr Opin Pharmacol; 2007 Apr; 7(2):214-8. PubMed ID: 17303472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic atrial dilation, electrical remodeling, and atrial fibrillation in the goat.
    Neuberger HR; Schotten U; Blaauw Y; Vollmann D; Eijsbouts S; van Hunnik A; Allessie M
    J Am Coll Cardiol; 2006 Feb; 47(3):644-53. PubMed ID: 16458150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphological remodeling in atrial fibrillation].
    Goette A; Lendeckel U
    Herz; 2006 Apr; 31(2):101-7; quiz 142-3. PubMed ID: 16738831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation.
    Greiser M; Neuberger HR; Harks E; El-Armouche A; Boknik P; de Haan S; Verheyen F; Verheule S; Schmitz W; Ravens U; Nattel S; Allessie MA; Dobrev D; Schotten U
    J Mol Cell Cardiol; 2009 Mar; 46(3):385-94. PubMed ID: 19100271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Remodelling in atrial fibrillation].
    Lévy S; Sbragia P
    Arch Mal Coeur Vaiss; 2005 Apr; 98(4):308-12. PubMed ID: 15881846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation begets atrial fibrillation in the pulmonary veins on the impact of atrial fibrillation on the electrophysiological properties of the pulmonary veins in humans.
    Rostock T; Steven D; Lutomsky B; Servatius H; Drewitz I; Klemm H; Müllerleile K; Ventura R; Meinertz T; Willems S
    J Am Coll Cardiol; 2008 Jun; 51(22):2153-60. PubMed ID: 18510963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of electrical remodeling in atrial fibrillation.
    Van Wagoner DR; Nerbonne JM
    J Mol Cell Cardiol; 2000 Jun; 32(6):1101-17. PubMed ID: 10888261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The electrocardiology of atrial fibrillation].
    Costantini M; Crema A
    Ital Heart J Suppl; 2000 May; 1(5):632-40. PubMed ID: 10834128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of electrical remodeling after cardioversion of persistent atrial fibrillation.
    Raitt MH; Kusumoto W; Giraud G; McAnulty JH
    J Cardiovasc Electrophysiol; 2004 May; 15(5):507-12. PubMed ID: 15149416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs.
    Shiroshita-Takeshita A; Sakabe M; Haugan K; Hennan JK; Nattel S
    Circulation; 2007 Jan; 115(3):310-8. PubMed ID: 17224477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of atrial remodeling and clinical relevance.
    Nattel S; Shiroshita-Takeshita A; Cardin S; Pelletier P
    Curr Opin Cardiol; 2005 Jan; 20(1):21-5. PubMed ID: 15596955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part II: New insights into the electrophysiological mechanisms of atrial fibrillation termination.
    Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
    Ital Heart J; 2003 Jul; 4(7):442-7. PubMed ID: 14558294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.
    Burstein B; Nattel S
    J Am Coll Cardiol; 2008 Feb; 51(8):802-9. PubMed ID: 18294563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical assessment of antiarrhythmic agents for paroxysmal atrial fibrillation guided by modification of electrophysiologic arrhythmogenicity.
    Sasano T; Okishige K; Azegami K; Isobe M
    J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1250-7. PubMed ID: 15574173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is atrial remodeling a viable target for prevention of atrial fibrillation recurrence?
    Nattel S
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):885-6. PubMed ID: 15333079
    [No Abstract]   [Full Text] [Related]  

  • 19. Atrial fibrillation in heart failure: steady progress but still a long way to go.
    Stambler BS; Laurita KR
    Circ Arrhythm Electrophysiol; 2008 Jun; 1(2):77-9. PubMed ID: 19808396
    [No Abstract]   [Full Text] [Related]  

  • 20. [Molecular basis of remodelling in atrial fibrillation].
    Dobrev D
    Dtsch Med Wochenschr; 2004 Apr; 129(15):827-30. PubMed ID: 15054689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.